Table 1.

Patient characteristics.

	Active GCA	Inactive GCA	Active TA	Inactive TA
	n = 6	n = 5	n = 10	n = 10
Age, med (min; max)	77.4 (58.2; 84)	70.1 (64; 80)	43.8 (23.6; 61)	41.4 (23.1; 70.6)
Gender, female, n (%)	3 (50)	3 (60)	8 (80)	9 (90)
Time from diagnosis, med (min; max)	2 (0; 5.5)	2.6 (1.5; 4.5)	2.8 (0.1; 11.6)	4.2 (0.2; 19.8)
Treatment
Immunosuppressant, n (%)	1 (16.7)	0 (0)	4 (40)	4 (40)
TNF inhibitors, n (%)	0 (0)	0 (0)	2 (20)	2 (20)
IL-6 inhibitors, n (%)	0 (0)	0 (0)	0 (0)	1 (10)
Corticosteroids, n (%)	3 (50)	4 (80)	5 (50)	7 (70)
Dose of corticosteroids, med (min; max)	15 (5; 25)	11 (5; 50)	8 (5; 10)	10 (5; 30)
Pulses of corticosteroids	0 (0)	0 (0)	2 (20)	0 (0)
Antibiotics	0 (0)	1 (20)	0 (0)	0 (0)
Symptoms
Ocular symptoms	3 (50)	0 (0)	1 (10)	1 (10)
Articular involvement	1 (16.7)	0 (0)	0 (0)	1 (10)
Cranial symptoms	3 (50)	1 (20)	0 (0)	1 (10)
Carotidynia	0 (0)	0 (0)	3 (30)	1 (10)
Claudication of arm	0 (0)	0 (0)	4 (40)	3 (30)
Claudication of leg	0 (0)	0 (0)	3 (30)	2 (20)
Dyspnoea	0 (0)	0 (0)	1 (10)	0 (0)
C-reactive protein (mg/l), mean (+ /− SD)	11.1 (12.8)	5.3 (6.1)	21.6 (23.6)	3 (5.1)